Please Wait
Applying Filters...
menu
    • menu
    Medical Breakthroughs in 2024: Alzheimer’s, schizophrenia, COPD, MASH see pathbreaking treatments

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Oct 2024: Lundbeck acquires Longboard for US$ 2.6 bn; molecular glue degrader tech witnesses dealmaking

    Stock Recap
    #PipelineProspector

    Menu

    Tenoxicam

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 501Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    28/10/2024 Zhejiang Hengkang Pharmaceutical
    China
    		 ZHEJIANG HENGKANG PHARMACEUTICAL CO., LTD. Sanmen CN R1-CEP 2011-331 - Rev 02 Tenoxicam 2019-11-18 Valid Chemical 1156
    28/10/2024 Esteve Quimica
    Spain
    		 ESTEVE QUIMICA S.A. Barcelona ES R1-CEP 1999-114 - Rev 02 Tenoxicam 2009-07-09 Withdrawn by Holder Chemical 2018-09-12 1156